Choonara I A, Cholerton S, Haynes B P, Breckenridge A M, Park B K
Br J Clin Pharmacol. 1986 Mar;21(3):271-7. doi: 10.1111/j.1365-2125.1986.tb05190.x.
The stereoselectivity of the pharmacokinetic interaction between warfarin and cimetidine was investigated in eight healthy volunteers. The warfarin enantiomers were given separately as single doses (15 mg) alone and during chronic administration of cimetidine (1 g day-1). Cimetidine did not interact with S warfarin but there was an interaction with the R enantiomer of warfarin. Cimetidine caused a significant increase in the mean plasma half-life of R warfarin (from 47.8 h to 57.8 h) and a significant decrease in its mean plasma clearance (from 2.3 to 1.7 ml h-1 kg-1) (P less than 0.02). Administration of a pharmacological dose of vitamin K1 together with the enantiomers of warfarin was necessary clinically and resulted in elevation of vitamin K1 2,3-epoxide concentrations, which were similar in each case.
在8名健康志愿者中研究了华法林与西咪替丁药代动力学相互作用的立体选择性。华法林对映体分别单次给药(15毫克),一次是单独给药,另一次是在西咪替丁长期给药期间(1克/天)。西咪替丁与S-华法林无相互作用,但与华法林的R对映体有相互作用。西咪替丁使R-华法林的平均血浆半衰期显著延长(从47.8小时延长至57.8小时),其平均血浆清除率显著降低(从2.3降至1.7毫升/小时/千克)(P<0.02)。临床上,给予药理剂量的维生素K1与华法林对映体同时使用是必要的,这导致维生素K1 2,3-环氧化物浓度升高,每种情况下浓度相似。